This is to inform that the company has received listing approval from the Stock Exchange for 1,55,10,000 equity shares of the company pursuant to the conversion of 1,55,10,000 warrants ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
BSE has granted listing approval for 1,55,10,000 equity shares of Integrated Proteins Ltd, each with a face value of Rs. 10 issued at a premium of Rs. 1.25 (total issue price Rs. 11.25 per share). These shares were allotted to non-promoters on a preferential basis following the conversion of warrants. The shares carry distinctive numbers from 3203601 to 18713600. Trading approval is still pending and will be granted only after the company files NSE listing approval (if applicable), NSDL/CDSL credit confirmations, and lock-in confirmations for pre-preferential holdings. The company must apply for trading approval within seven working days of this listing approval or face penalties.
This is a routine regulatory step enabling warrant-converted shares to be tradable on the exchange, which increases the company's listed share count and float. For existing shareholders, it means potential dilution has been formally listed; the stock may see supply pressure once trading approval is received and lock-in periods expire on the newly issued shares.